JPWO2023009498A5 - - Google Patents
Info
- Publication number
- JPWO2023009498A5 JPWO2023009498A5 JP2024504840A JP2024504840A JPWO2023009498A5 JP WO2023009498 A5 JPWO2023009498 A5 JP WO2023009498A5 JP 2024504840 A JP2024504840 A JP 2024504840A JP 2024504840 A JP2024504840 A JP 2024504840A JP WO2023009498 A5 JPWO2023009498 A5 JP WO2023009498A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- antibody
- cells
- klrg1
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225828P | 2021-07-26 | 2021-07-26 | |
| US63/225,828 | 2021-07-26 | ||
| US202263308222P | 2022-02-09 | 2022-02-09 | |
| US63/308,222 | 2022-02-09 | ||
| PCT/US2022/038310 WO2023009498A1 (en) | 2021-07-26 | 2022-07-26 | Killer cell lectin-like receptor subfamily g member 1 (klrg1) depleting antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024528877A JP2024528877A (ja) | 2024-08-01 |
| JP2024528877A5 JP2024528877A5 (https=) | 2025-08-04 |
| JPWO2023009498A5 true JPWO2023009498A5 (https=) | 2025-08-04 |
Family
ID=85087207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504840A Pending JP2024528877A (ja) | 2021-07-26 | 2022-07-26 | キラー細胞レクチン様受容体サブファミリーｇメンバー１（ｋｌｒｇ１）枯渇性抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250101112A1 (https=) |
| EP (1) | EP4377346A1 (https=) |
| JP (1) | JP2024528877A (https=) |
| AU (1) | AU2022320627A1 (https=) |
| CA (1) | CA3227742A1 (https=) |
| MX (1) | MX2024001277A (https=) |
| WO (1) | WO2023009498A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025147544A1 (en) | 2024-01-02 | 2025-07-10 | Abcuro, Inc. | Methods of treating inclusion body myositis (ibm) |
| WO2026072990A1 (en) | 2024-09-27 | 2026-04-02 | Abcuro, Inc. | Methods of treating t-cell large granular lymphocytic leukemia |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4474893A (en) | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| EP0098110B1 (en) | 1982-06-24 | 1989-10-18 | NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD | Long-acting composition |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| AU597574B2 (en) | 1986-03-07 | 1990-06-07 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| ATE300615T1 (de) | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US6030613A (en) | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
| GB0029407D0 (en) | 2000-12-01 | 2001-01-17 | Affitech As | Product |
| BR112012000536A2 (pt) | 2009-07-08 | 2020-08-11 | Kymab Limited | métodos para produção de anticorpo ou cadeia leve ou pesada de anticorpo específico para um antígeno desejado, para produção de anticorpo ou cadeia de anticorpo e seu uso, composição farmacêutica e derivado de anticorpo quimérico |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| AU2017326003A1 (en) | 2016-09-16 | 2019-04-11 | Children's Medical Center Corporation | KLRG1 depletion therapy |
| US20210002373A1 (en) * | 2018-03-01 | 2021-01-07 | Nextcure, Inc. | KLRG1 Binding Compositions and Methods of Use Thereof |
| EP3952999A4 (en) | 2019-04-09 | 2023-01-25 | Abcuro, Inc. | Killer cell lectin-like receptor subfamily g member 1 (klrg1) depleting antibodies |
-
2022
- 2022-07-26 MX MX2024001277A patent/MX2024001277A/es unknown
- 2022-07-26 EP EP22755009.2A patent/EP4377346A1/en active Pending
- 2022-07-26 US US18/291,013 patent/US20250101112A1/en active Pending
- 2022-07-26 WO PCT/US2022/038310 patent/WO2023009498A1/en not_active Ceased
- 2022-07-26 AU AU2022320627A patent/AU2022320627A1/en active Pending
- 2022-07-26 CA CA3227742A patent/CA3227742A1/en active Pending
- 2022-07-26 JP JP2024504840A patent/JP2024528877A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2563830C2 (ru) | Лечение остеоартрита и боли | |
| CN106554417B (zh) | 抗ox40抗体和使用其的方法 | |
| JP2023123627A5 (https=) | ||
| RU2019134352A (ru) | Новые биспецифические антигенсвязывающие молекулы, обладающие способностью специфически связываться с cd40 и fap | |
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| JP2020528768A5 (https=) | ||
| JP2011506483A5 (https=) | ||
| RU2009136913A (ru) | Биспецифические связывающие агенты с межвидовой специфичностью | |
| RU2008149918A (ru) | Антитела к nkg2a и их применения | |
| RU2012119788A (ru) | Связывающие il-1 белки | |
| KR20110110349A (ko) | Ｉｌ-1 결합 단백질 | |
| JPWO2019246514A5 (https=) | ||
| JPWO2020132066A5 (https=) | ||
| CN109999195A (zh) | 类风湿关节炎的治疗 | |
| JP2024024114A5 (https=) | ||
| JPWO2020113194A5 (https=) | ||
| WO2013140787A1 (ja) | 特発性炎症性筋疾患の予防又は治療剤 | |
| CN119095619A (zh) | 抗cd19药剂的剂量方案及其用途 | |
| JPWO2019246356A5 (https=) | ||
| JPWO2020210512A5 (https=) | ||
| JPWO2021163389A5 (https=) | ||
| JPWO2023009498A5 (https=) | ||
| IL314344A (en) | Bispecific antibodies against CD3 and CD20 in combination therapy for the treatment of diffuse large B-cell lymphoma | |
| JPWO2020172475A5 (https=) | ||
| JPWO2023031403A5 (https=) |